WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gwenn HansenChief Scientific Officer2026-02-0331,333$0.84
$26.32kBuy
Houte Hans VanChief Financial Officer2026-01-3073$17.37
$1.27kSell
Houte Hans VanChief Financial Officer2026-01-303,588$16.58
$59.50kSell
Christine RingChief Legal Officer2026-01-304,333$16.58
$71.85kSell
Gwenn HansenChief Scientific Officer2026-01-304,797$16.58
$79.55kSell
Gwenn HansenChief Scientific Officer2026-01-3098$17.37
$1.70kSell
Christine RingChief Legal Officer2026-01-3088$17.37
$1.53kSell
Christine RingChief Legal Officer2026-01-203,760$18.42
$69.27kSell
Christine RingChief Legal Officer2026-01-203,760$1.86
$6.99kBuy
Christine RingChief Legal Officer2025-12-18200$18.56
$3.71kSell

1 of 3

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC8.64%8,887,537$149.22MInstitution
Blackrock Inc6.58%6,762,586$113.54MInstitution
Deep Track Capital LP5.89%6,057,024$101.70MInstitution
Vanguard Group Inc4.36%4,488,776$75.37MInstitution
Baker Bros Advisors LP3.77%3,882,125$65.18MInstitution
Commodore Capital LP3.68%3,780,055$63.47MInstitution
Redmile Group LLC3.58%3,678,394$61.76MInstitution
Third Rock Ventures III LP3.41%3,509,348$58.92MInsider
Vestal Point Capital LP3.38%3,475,000$58.35MInstitution
Point72 Asset Management LP2.79%2,871,497$48.21MInstitution

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX82.43%8.29%Net SellingNet Buying
MBX44.21%55.79%Net Buying
PHVS89.05%0.00%
DFTX40.33%45.42%Net SellingNet Selling
ZYME52.53%47.47%Net BuyingNet Selling
View Top Biotech Stocks

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 82.43% institutional shareholders, 8.29% Nurix Therapeutics insiders, and 9.28% retail investors. Third Rock Ventures III LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 3.41% of the company. Third Rock Ventures III LP's Nurix Therapeutics shares are currently valued at $58.08M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.